University of Michigan
Ann Arbor, Michigan, United States
Andrew J. Scott, PhD is an NCI-sponsored Postdoctoral Research Fellow in the Department of Radiation Oncology at the University of Michigan. As a Fellow under the mentorship of Dr. Daniel Wahl and Dr. Costas Lyssiotis, his translational research focuses on understanding the rewiring of glioblastoma (GBM) metabolism in animal models and human patients with brain cancer. His laboratory work forms the basis for multiple clinical trials at the University of Michigan, in which he is a co-investigator and onsite lead, that directly measure and inhibit tumor metabolic activity in patients with GBM. Dr. Scott’s long-term research goals aim to improve both our understanding of glioma metabolism and our ability to target aberrant metabolic activity in tumors for therapeutic benefit. His research has been supported by awards including the Ruth L. Kirschstein Postdoctoral Individual National Research Service Award (F32), the University of Michigan Cancer Biology T32 Training Program, and the Rogel Cancer Center Postdoctoral Scholarship.
